Medicines account for more than 13 per cent – about €3.3 billion – of a health budget that is permanently under strain. That ...
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Medicines Agency (EMA) has validated for parallel accelerated review the company’s ...
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
One of the main challenges identified by the research was that, although the European Medicines Agency (EMA) approves new ...
C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to ...
Gilead Sciences, Inc. has received conditional marketing authorization from the European Commission (EC) for Seladelpar for the treatment of primary biliary cholangitis (PBC) ...
Belgian MEP Liesbet Sommen spoke with Euractiv about critical medicines shortages, EU Pharma Package progress, and SANT's evolving role.
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a ...